Breaking News Instant updates and real-time market news.

NEWR

New Relic

$106.95

4 (3.89%)

16:10
05/14/19
05/14
16:10
05/14/19
16:10

New Relic reports Q4 adjusted EPS 13c, consensus 6c

Reports Q4 revenue $132.1M, consensus $128.1M.

  • 14

    May

  • 14

    May

  • 21

    May

  • 29

    May

  • 30

    May

  • 13

    Nov

NEWR New Relic
$106.95

4 (3.89%)

02/07/19
OPCO
02/07/19
NO CHANGE
Target $125
OPCO
Outperform
New Relic price target raised to $125 from $110 at Oppenheimer
Oppenheimer analyst Ittai Kidron raised his price target for New Relic to $125 from $110 after the company delivered another "strong" quarter ahead of expectations, driven by steady execution, broadbased product demand, and increased large deal activity. The analyst sees a long runway for growth as New Relic focuses on driving larger deal sizes and multi-product use with larger customers. He is also positive on New Relic's acquisition of SignifAI, which adds event intelligence and AI/ML capabilities that will strengthen New Relic's ability to provide end-to-end and contextual visibility in a single-platform. Kidron reiterates an Outperform rating on the shares.
02/07/19
WEDB
02/07/19
NO CHANGE
Target $124
WEDB
Outperform
New Relic price target raised to $124 from $116 at Wedbush
Wedbush analyst Steve Koenig raised his price target for New Relic to $124 from $116 after the company posted its biggest revenue beat to date, and guided FY19 revenue up by a solid $6M. While Koenig notes that some analysts expressed disappointment that Q4 deferred revenue guidance was up quarter over quarter in the low-20% range, he is "not concerned," as the guidance beats his target, and he expects some upside. The analyst does not expect further upward rerating of multiples, but healthy growth with modest deceleration provides a good opportunity for further stock appreciation. He reiterates an Outperform rating on the shares.
02/07/19
DADA
02/07/19
NO CHANGE
Target $125
DADA
Buy
New Relic price target raised to $125 from $105 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on New Relic to $125 and kept his Buy rating after its strong Q3 results driven by the "upside in revenue per paid business account" of over $29K - above the consensus of $27.8K. The analyst adds that the company's cross-selling efforts remained strong and maintains his view of New Relic as one of "prime beneficiaries of the ongoing trend of digital transformation".
02/27/19
WEDB
02/27/19
NO CHANGE
Target $124
WEDB
Outperform
New Relic added to Best Ideas List at Wedbush
Wedbush analyst Steve Koenig added New Relic to his firm's Best Ideas List, saying he is bullish on it based on growing enterprise penetration and a promising setup heading into FY20/March. Per his proprietary analysis, New Relic has now penetrated over 50% of the Fortune 100 and is increasing its lead in the cloud, putting it in a good position to claim overall leadership in the application performance management market as application development shifts to the cloud. The analyst expects continued upward revisions to consensus estimates throughout FY20. Koenig reiterates an Outperform rating and $124 price target on the shares.

TODAY'S FREE FLY STORIES

TWTR

Twitter

$37.19

-1.31 (-3.40%)

05:58
05/24/19
05/24
05:58
05/24/19
05:58
Periodicals
Twitter permanently bans anti-Trump Krassenstein brothers, Daily Beast reports »

Twitter has permanently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSG

Inseego

$5.18

-0.26 (-4.78%)

05:49
05/24/19
05/24
05:49
05/24/19
05:49
Initiation
Inseego initiated  »

Inseego initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$33.07

-0.4 (-1.20%)

05:45
05/24/19
05/24
05:45
05/24/19
05:45
Recommendations
Nektar analyst commentary  »

Mizuho reiterates $81…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 12

    Jun

SINA

Sina

$42.56

-4.94 (-10.40%)

05:45
05/24/19
05/24
05:45
05/24/19
05:45
Downgrade
Sina rating change  »

Sina downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$15.57

-0.29 (-1.83%)

05:44
05/24/19
05/24
05:44
05/24/19
05:44
Upgrade
Vodafone rating change  »

Vodafone upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SR

Spire

$85.92

0.26 (0.30%)

05:43
05/24/19
05/24
05:43
05/24/19
05:43
Downgrade
Spire rating change  »

Spire downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

VEEV

Veeva

$140.80

-3.74 (-2.59%)

05:43
05/24/19
05/24
05:43
05/24/19
05:43
Downgrade
Veeva rating change  »

Veeva downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

VALE

Vale

$11.78

0.03 (0.26%)

05:41
05/24/19
05/24
05:41
05/24/19
05:41
Upgrade
Vale rating change  »

Vale upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STZ

Constellation Brands

$206.21

0.96 (0.47%)

05:39
05/24/19
05/24
05:39
05/24/19
05:39
Downgrade
Constellation Brands rating change  »

Constellation Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$276.46

-1.35 (-0.49%)

05:39
05/24/19
05/24
05:39
05/24/19
05:39
Downgrade
Lennox rating change  »

Lennox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

TOO

Teekay Offshore Partners

$1.11

0.005 (0.45%)

, BBU

Brookfield Business Partners

$37.63

-0.43 (-1.13%)

05:36
05/24/19
05/24
05:36
05/24/19
05:36
Hot Stocks
JDP finds support from other Teekay Offshore holders to oppose Brookfield deal »

On May 17, Brookfield…

TOO

Teekay Offshore Partners

$1.11

0.005 (0.45%)

BBU

Brookfield Business Partners

$37.63

-0.43 (-1.13%)

TK

Teekay Corp.

$3.86

-0.35 (-8.31%)

BAM

Brookfield

$46.55

-0.25 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 08

    Aug

NGLOY

Anglo American

$0.00

(0.00%)

05:33
05/24/19
05/24
05:33
05/24/19
05:33
Upgrade
Anglo American rating change  »

Anglo American upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

05:29
05/24/19
05/24
05:29
05/24/19
05:29
Downgrade
Weibo rating change  »

Weibo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$276.46

-1.35 (-0.49%)

05:28
05/24/19
05/24
05:28
05/24/19
05:28
Downgrade
Lennox rating change  »

Lennox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

GMED

Globus Medical

$40.59

-0.84 (-2.03%)

05:26
05/24/19
05/24
05:26
05/24/19
05:26
Downgrade
Globus Medical rating change  »

Globus Medical downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

BCRX

BioCryst

$3.54

0.09 (2.61%)

05:25
05/24/19
05/24
05:25
05/24/19
05:25
Downgrade
BioCryst rating change  »

BioCryst downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

MRBK

Meridian Bank

$16.95

(0.00%)

05:25
05/24/19
05/24
05:25
05/24/19
05:25
Earnings
Meridian reports Q1 EPS 31c, consensus 22c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$282.19

-3.43 (-1.20%)

05:24
05/24/19
05/24
05:24
05/24/19
05:24
General news
U.K. Prime Minister Theresa May announces she'll step down on June 7 »

In a public address,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$282.19

-3.43 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$67.13

-1.42 (-2.07%)

05:20
05/24/19
05/24
05:20
05/24/19
05:20
Recommendations
Ionis Pharmaceuticals analyst commentary  »

Piper 'incrementally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 17

    Jun

  • 18

    Jun

ADSK

Autodesk

$169.64

-4.47 (-2.57%)

05:14
05/24/19
05/24
05:14
05/24/19
05:14
Recommendations
Autodesk analyst commentary  »

Autodesk Q1 results did…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jun

  • 12

    Jun

SPLK

Splunk

$128.68

-7.12 (-5.24%)

05:10
05/24/19
05/24
05:10
05/24/19
05:10
Recommendations
Splunk analyst commentary  »

Splunk exceeded most…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

  • 09

    Jul

AMZN

Amazon.com

$1,815.30

-42.44 (-2.28%)

05:06
05/24/19
05/24
05:06
05/24/19
05:06
Recommendations
Amazon.com analyst commentary  »

Amazon shares will rally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 25

    Jun

AAXN

Axon

$67.06

-1.29 (-1.89%)

04:58
05/24/19
05/24
04:58
05/24/19
04:58
Downgrade
Axon rating change  »

Axon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

KTB

Kontoor Brands

$38.51

0.82 (2.18%)

, ORN

Orion Group

$1.87

-0.12 (-6.03%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Hot Stocks
Kontoor Brands to replace Orion Group in S&P 600 at open on 5/24 »

V.F. Corp. (VFC) is…

KTB

Kontoor Brands

$38.51

0.82 (2.18%)

ORN

Orion Group

$1.87

-0.12 (-6.03%)

VFC

VF Corp.

$84.06

-6.32 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

04:55
05/24/19
05/24
04:55
05/24/19
04:55
General news
Breaking General news story  »

Week of 5/24 Baker-Hughes…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.